Literature DB >> 15919888

BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.

Prasanna M Bhende1, William T Seaman, Henri-Jacques Delecluse, Shannon C Kenney.   

Abstract

The Epstein-Barr virus (EBV) genome is highly methylated in latently infected cells. We recently reported that the EBV immediate-early (IE) protein BZLF1 (Z) preferentially binds to and activates transcription from the methylated form of the BRLF1 IE gene promoter (Rp). We now report that serine residue 186 in the Z DNA-binding domain plays an important role in the ability of Z to bind to and activate methylated Rp. A Z mutant containing an alanine residue at position 186 [Z(S186A)] was significantly defective in binding to methylated, as well as unmethylated, ZREs (Z-responsive elements) in Rp and was unable to activate lytic EBV gene transcription from the methylated or demethylated form of the viral genome. A Z mutant containing threonine at residue 186 [Z(S186T)] bound only to the methylated form of the ZRE-2 site in Rp and induced lytic EBV gene transcription from the methylated, but not demethylated, form of the viral genome. The defect in both of these mutants was primarily due to an inability to activate the Rp in the context of the viral genome. Finally, a Z mutant containing an aspartic acid at position 186 [Z(S186D)] did not bind to either the consensus AP-1 site or to the methylated or unmethylated Rp ZRE-2 site and did not induce lytic gene transcription. These results indicate that replacement of serine with threonine at residue 186 in the Z DNA-binding domain differentially affects its ability to reactivate the unmethylated, versus methylated, viral genome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919888      PMCID: PMC1143640          DOI: 10.1128/JVI.79.12.7338-7348.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome.

Authors:  Prasanna M Bhende; William T Seaman; Henri-Jacques Delecluse; Shannon C Kenney
Journal:  Nat Genet       Date:  2004-09-12       Impact factor: 38.330

2.  Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.

Authors:  C Rooney; N Taylor; J Countryman; H Jenson; J Kolman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

4.  Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

5.  Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter.

Authors:  F Watt; P L Molloy
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

Review 6.  DNA methylation and gene activity.

Authors:  W Doerfler
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  Chromatin structure is required to block transcription of the methylated herpes simplex virus thymidine kinase gene.

Authors:  G Buschhausen; B Wittig; M Graessmann; A Graessmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Epstein-Barr virus replication in oropharyngeal epithelial cells.

Authors:  J W Sixbey; J G Nedrud; N Raab-Traub; R A Hanes; J S Pagano
Journal:  N Engl J Med       Date:  1984-05-10       Impact factor: 91.245

9.  Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.

Authors:  Anthony T C Chan; Qian Tao; Keith D Robertson; Ian W Flinn; Risa B Mann; Barbara Klencke; Wing Hong Kwan; Thomas Wai-Tong Leung; Philip J Johnson; Richard F Ambinder
Journal:  J Clin Oncol       Date:  2004-03-08       Impact factor: 44.544

10.  Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.

Authors:  A Chevallier-Greco; E Manet; P Chavrier; C Mosnier; J Daillie; A Sergeant
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  54 in total

1.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

2.  Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication.

Authors:  Andrew J Rennekamp; Pu Wang; Paul M Lieberman
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Authors:  Nicolae Balan; Kay Osborn; Alison J Sinclair
Journal:  J Gen Virol       Date:  2015-12-11       Impact factor: 3.891

4.  Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain.

Authors:  Pu Wang; Latasha Day; Paul M Lieberman
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

5.  Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.

Authors:  Lee Heston; Ayman El-Guindy; Jill Countryman; Charles Dela Cruz; Henri-Jacques Delecluse; George Miller
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Epstein-Barr virus transcription activator R upregulates BARF1 expression by direct binding to its promoter, independent of methylation.

Authors:  E K Hoebe; C Wille; E S Hopmans; A R Robinson; J M Middeldorp; S C Kenney; A E Greijer
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

7.  AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome.

Authors:  Markus Kalla; Anne Schmeinck; Martin Bergbauer; Dagmar Pich; Wolfgang Hammerschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.

Authors:  Amanda R Robinson; Swee Sen Kwek; Stacy R Hagemeier; Coral K Wille; Shannon C Kenney
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

9.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

10.  The de novo methyltransferases DNMT3a and DNMT3b target the murine gammaherpesvirus immediate-early gene 50 promoter during establishment of latency.

Authors:  Kathleen S Gray; J Craig Forrest; Samuel H Speck
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.